Profiting from mental ill-health
There’s a reason psychiatrists prescribe drugs rather than talking therapy: the latter makes no money for pharmaceutical firms
Psychotherapist Harriet Fraad of New York City lambasts psychiatric drugs:
“Do these psycho pharmaceuticals work to restore mental health? Actually, the evidence is overwhelming that they fail. Antidepressants, the most popular psycho-pharmaceuticals, work no better than placebos. They work 25% of the time and stop working when the user stops taking them. In addition, they may actually harm patients in the long run. They disrupt brain neurotransmitters and may usurp the brain’s organic soothing functions.
“All 30 of the available antidepressants have suffered lawsuits within five years of their appearance on the market. These suits are often settled with large payments and gag clauses. … Every major company selling anti-psychotics – Bristol Meyers Squibb, Eli Lilly, Pfizer, Johnson and Johnson and AstraZeneca – has either settled investigations for healthcare fraud or is currently being investigated for it.
“Experts agree that there is no long-term improvement in children’s lives from taking anti-psychotic drugs. In fact, these drugs have a substantiated pattern of metabolic problems and rapid weight gain that often leads to diabetes. The use of bipolar diagnoses and bipolar medications is one small example of how market-driven mental healthcare works in the United States. It illustrates the transformation of US healthcare into a system dominated by some of the richest corporations in the world.
“Caring about profit is first, and that is why psychiatry has turned to drug therapy.”
Of course, we do not recommend psychiatric treatment of any kind, drugs or talk therapy. There are good reasons why we do not recommend psychiatric treatment. We do recommend informed consent, and sound medical diagnosis and treatment. For more information, download and read the free CCHR booklet, “Psychiatric Hoax — The Subversion of Medicine.”